Beranda › Limfoma Burkitt › New Jersey › Paterson
Uji klinis Limfoma Burkitt di Paterson, NJ
4 studi untuk Limfoma Burkitt mencari peserta di lokasi sekitar Paterson (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.
Teks studi resmi (Bahasa Inggris)
Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
Menerima pesertaFase 2
- Saint Joseph's Regional Medical Center, Paterson
Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia
Menerima pesertaFase 2
- Saint Joseph's Regional Medical Center, Paterson
A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)
Menerima pesertaFase 2
- Saint Joseph's Regional Medical Center, Paterson
Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy
Menerima pesertaFase 3
- Saint Joseph's Regional Medical Center, Paterson
Uji klinis Limfoma Burkitt di kota lain
- Houston, TX21 studi
- Milwaukee, WI16 studi
- Philadelphia, PA16 studi
- New York City, NY14 studi
- Chicago, IL14 studi
- Cincinnati, OH12 studi
- Atlanta, GA12 studi
- Seattle, WA11 studi
- Durham, NC10 studi
- Boston, MA10 studi
- Los Angeles, CA10 studi
- Aurora, CO10 studi
Studi lain di Paterson
- Kanker Payudara7 studi
- Leukemia Mieloid Akut7 studi
- Kanker Paru Non-Sel Kecil6 studi
- Kanker Paru5 studi
- Melanoma5 studi
- Gagal Jantung4 studi
- Stenosis Katup Aorta4 studi
- Kanker (semua jenis)4 studi
- Penyakit Hati Steatotik3 studi
- Penyakit Arteri Koroner3 studi
- Neoplasma Mieloproliferatif3 studi
- Kanker Prostat3 studi
Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.